Keyphrases
Africa
100%
Black African
100%
Warfarin
100%
Hypertension Guidelines
62%
South Africa
60%
Atrial Fibrillation
58%
Black South African Patients
56%
Systolic Blood Pressure
54%
Sub-Saharan Africa
52%
New-onset Atrial Fibrillation
50%
1-year Outcome
50%
Hypertension
50%
Chronic Kidney Disease
50%
Patient Management
50%
Moderate to Severe
50%
Clopidogrel
50%
Kidney Disease Progression
50%
Multicenter Trial
50%
Blood Pressure Lowering
50%
Dosing Algorithm
50%
Warfarin Pharmacogenetics
50%
Supratherapeutic INR
50%
Mechanical Heart Valve Prostheses
50%
INR Control
50%
Self-competence
50%
Generalist
50%
Electrocardiogram Interpretation
50%
Self-rating
50%
Rheumatic Heart Disease
50%
Tuberculous Pericarditis
50%
Oral Anticoagulation
50%
Combination Therapy
50%
Genetic Variants
50%
Pharmacokinetics
50%
Heart Failure with Preserved Ejection Fraction (HFpEF)
50%
Initial Management
50%
Clinical Characteristics
50%
Academic Hospital
50%
Addis Ababa
50%
Genetic Markers
50%
AIDS/HIV
50%
Aspirin
50%
Pericarditis
50%
CYP2C9
50%
Confidence Interval
47%
Prothrombin Time-international Normalized Ratio
43%
Executive Committee
33%
Bileaflet Mechanical Heart Valve
31%
Randomized Controlled Trial
29%
Anticoagulants
28%
CYP2C8
28%
Asia
28%
Odds Ratio
27%
Rheumatic Fever
25%
Placebo
25%
Perindopril
25%
Hydrochlorothiazide
25%
Amlodipine
25%
People of Color
25%
Stroke Risk
24%
Human Immunodeficiency Virus Infection
22%
Fibrillation
21%
Warfarin Maintenance Dose
21%
Chronic Kidney Disease Stage
21%
Warfarin Dose
21%
African Ancestry
21%
South African
20%
Relative Risk
20%
Systemic Embolism
19%
Major Bleeding
19%
Anticoagulation
18%
Medical Association
16%
Consensus Conference
16%
Triple Therapy
16%
Type 1 Diabetes Mellitus (T1DM)
16%
Primary Care
16%
Blood Pressure Target
16%
Virus Status
16%
Myopericarditis
16%
Southern African
16%
Correct Answer
16%
Cardiac Anomalies
16%
Black Population
16%
Genetic Variation
14%
Rest of the World
14%
VKORC1
14%
Dose Variability
14%
CYP2C
14%
SNP
14%
CYP3A5
14%
Mixed Ancestry
14%
Medical Records
13%
Primary Outcome Measure
12%
Drug Combination
12%
Unique Information
12%
Background Current
12%
Best Combination
12%
Hypertensive Patients
12%
Hypertension Management
12%
Clinical Practice Guidelines
12%
Medicine and Dentistry
Congestive Heart Failure
58%
Atrial Fibrillation
54%
Anticoagulation
50%
Chronic Kidney Disease
50%
Diabetic Hypertension
50%
Heart Valve Prosthesis
50%
Warfarin
50%
Mechanical Heart Valve
50%
Tuberculous Pericarditis
50%
Randomized Controlled Trial
50%
Ejection Fraction
50%
Retrospective Study
50%
Electrocardiogram
50%
Diabetes Mellitus
50%
Systolic Blood Pressure
50%
Blood Pressure
50%
Human Immunodeficiency Virus
50%
Antihypertensive Agent
50%
Pericarditis
50%
Self Concept
50%
Rheumatic Heart Disease
50%
Prothrombin Time
43%
Rheumatic Fever
25%
Odds Ratio
25%
Antithrombotic
21%
Hemodynamic
17%
Apoplexy
15%
Fibrillation
10%
Brain Natriuretic Peptide
10%
Amino Terminal Sequence
10%
Dyspnea
10%
Clinical Feature
10%
Chi Square Test
10%
Human Immunodeficiency Virus Infection
10%
Diagnosis
10%
Non Communicable Disease
10%
Virus Infection
10%
Mixed Infection
10%
Pericardial Disorder
10%
Informed Consent
8%
Primary Health Care
8%
Major Bleeding
7%
Arterial Stiffness
7%
Pulse Wave Velocity
7%
Galectin 3
7%
Medical Record
6%
Study Participant
6%
Valve Replacement
6%
Mitral Valve Replacement
6%
Prosthetic Replacement
6%
Cardiovascular System
5%
Health Service
5%
Diagnostic Test
5%
Disease
5%
Primary Prevention
5%
Secondary Prevention
5%
Cardiology
5%
Patient with Human Immunodeficiency Virus
5%
Reproductive Public Health
5%
Disease Burden
5%
Analysis of Variance
5%
Consultation
5%
Heart Disease
5%
Cardiomegaly
5%
Heart Death
5%
Benzathine Benzylpenicillin
5%
Communicable Disease Control
5%
Lifespan
5%
Heart Surgery
5%
Nursing and Health Professions
Atrial Fibrillation
54%
Congestive Heart Failure
53%
South Africa
53%
Physician
50%
Electrocardiogram
50%
Human Immunodeficiency Virus
50%
Chronic Kidney Failure
50%
Heart Ejection Fraction
50%
Pericarditis
50%
Tuberculous Pericarditis
50%
Odds Ratio
25%
Confidence Interval
25%
Anticoagulant Agent
21%
Cerebrovascular Accident
10%
Brain Natriuretic Peptide
10%
Human Immunodeficiency Virus Infection
10%
Dyspnea
10%
Clinical Feature
10%
Virus Infection
10%
Diagnosis
10%
Pericardial Disease
10%
Chi Square Test
10%
Mixed Infection
10%
Primary Health Care
8%
Pulse Wave
7%
Bleeding
7%
Arterial Stiffness
7%
Galectin 3
7%
Heart Disease
5%
Analysis of Variance
5%
Diagnostic Test
5%
Patient with Human Immunodeficiency Virus
5%
Cardiomegaly
5%